Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 15075324
Zou Y, et al. (2004) Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J Biol Chem 279, 27790-8 15075324
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T286-p - CCND1 (mouse)
Modsite: EEAGLACtPTDVRDV SwissProt Entrez-Gene
Orthologous residues
CCND1 (human): T286‑p, CCND1 (mouse): T286‑p, CCND1 (rat): T286‑p
Characterization
Methods used to characterize site in vivo [32P] bio-synthetic labeling, mutation of modification site
Relevant cell lines - cell types - tissues:  Mv1Lu (pulmonary)
Cellular systems studied:  cell lines
Species studied:  mink
Enzymes shown to modify site in vitro
Type Enzyme
KINASE GSK3B (mouse)
KINASE DYRK1B (mouse)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE DYRK1B (mouse) transfection of constitutively active enzyme, transfection of wild-type enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
lithium decrease

T288-p - CCND1 (mouse)
Modsite: AGLACTPtDVRDVDI SwissProt Entrez-Gene
Orthologous residues
CCND1 (human): T288‑p, CCND1 (mouse): T288‑p, CCND1 (rat): T288‑p
Characterization
Methods used to characterize site in vivo [32P] bio-synthetic labeling, mutation of modification site
Relevant cell lines - cell types - tissues:  Mv1Lu (pulmonary)
Cellular systems studied:  cell lines
Species studied:  mink
Enzymes shown to modify site in vitro
Type Enzyme
KINASE GSK3B (mouse)
KINASE DYRK1B (mouse)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE DYRK1B (mouse) transfection of constitutively active enzyme, transfection of wild-type enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
lithium decrease
Downstream Regulation
Effect of modification (function):  protein degradation